LCD L38016: MolDX: Melanoma Risk Stratification Molecular Testing — CGS
Policy LCD-L38016 · Dermatology
New molecular testing for melanoma risk effective June 2025.
Code intelligence
0578U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0578U.
Elevated code risk
Signal breakdown
6 shown · 6 total in platform
Risk: Elevated
0
Critical
0%
6
High
100%
0
Routine
0%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L37725: MolDX: Melanoma Risk Stratification Molecular Testing — Palmetto GBA
Policy LCD-L37725 · Dermatology
Prepare for changes in melanoma risk testing reimbursements.
LCD L37750: MolDX: Melanoma Risk Stratification Molecular Testing — Noridian
Policy LCD-L37750 · Oncology
New molecular testing guidelines for melanoma risk coming in 2026.
LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
LCD L37748: MolDX: Melanoma Risk Stratification Molecular Testing — Noridian
Policy LCD-L37748 · Oncology
Prepare for changes in melanoma testing billing by 2025.
LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
Audit documentation
Building an audit file that includes 0578U?
The Tripwire Audit Pack exports 12 months of Dermatology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Dermatology audit pack — $349One-time purchase · not a subscription